BRIACELL THERAPEUTICS CORP. Preferred Stock Dividends and Other Adjustments
BRIACELL THERAPEUTICS CORP. (BCTX) reported Preferred Stock Dividends and Other Adjustments of -$14.28 million for the 3-month period ending 2023-10-31, per its 10-Q filed 2023-12-14.
Discontinued › Expense Statement › Operating Expenses
us-gaap:PreferredStockDividendsAndOtherAdjustments · last filed 2023-12-14
- BRIACELL THERAPEUTICS CORP. preferred stock dividends and other adjustments for the quarter ending 2023-10-31 was -$14.28M.
| Period end | Preferred Stock Dividends and Other Adjustments 3 month |
|---|---|
| 2023-10-31 | -$14.28M 10-Q · filed 2023-12-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |